Advanced Biomed is trading 8.5% down at $9.22 as its sharp, multi-day selloff continues following the company’s abrupt cancellation of a planned securities offering.
- The stock has lost more than half its value over the past week, with traders increasingly wary of financing uncertainty and extreme volatility.
- Company-specific concerns are clearly dominating price action, despite a generally constructive sentiment across the broader biotech sector.